Our study adds evidence to the previously reported results that MDA in preterm born children has an effect not only on the central sensitivity under photopic conditions, but also on the speed of the dark-adaptation process. Others and we have shown a higher incidence of foveal abnormalities in SD-OCT examinations in infants and children with a history of ROP.
11,15–17 It was supposed that the morphologic and functional changes in the central fovea went along with parafoveal changes and impairments of photoreceptors before and on the rod ring at 18° eccentricity.
15 In line with this, affected children tested in our study showed significantly decelerated od-mediated dark adaptation kinetics at 12° temporal to the foveal center, reduced visual acuity, and lowered cone-mediated threshold in the central fovea measured with a recently developed fundus-controlled dark adaptometer.
The process of dark adaptation, or the slow recovery of visual sensitivity after exposure to intense light, is associated with the regeneration of visual pigment.
18 The elevation of the threshold for the detection of visual stimuli depends on the estimated bleach-level of rod and cone photopigments, and follows after a near-total bleach a classic biphasic form, with an early cone-mediated and a later rod-mediated phase.
19 The recovery of the rod-mediated threshold exhibits a region of typical slope across all bleach levels and is termed the S2 component of recovery.
20 It appears that this value is a universal characteristic of dark adaptation recovery in normal (young adult) human eyes and is widely independent of the proportion of the pretest bleach.
21,22 Opsin, produced by bleaching, was proposed to be the substance underlying the S2 component.
22 In healthy human eyes, the rate-limited regeneration of rhodopsin and the S2 component have a common origin in a resistive barrier between a source of 11-cis retinal (RPE) and the opsin molecules in the outer segments. In certain disease states, the rate of regeneration drops to a lower level as a result of reduced enzyme activity. The lowered S2 component in our patient group with MDA resembles findings in patients with early age-related maculopathy
23or patients with systemic vitamin A deficiency.
24 The final rhodopsin levels expressed as the final visual thresholds in all examined children were entirely average, indicating that the retina is otherwise functioning normally. The underlying morphologic deviations are yet to be clarified.
Our results of altered rod-mediated dark adaptation kinetics are in line with various other studies with electroretinography (ERG), psychophysical, and retinal imaging procedures that showed persistent effects on rod photoreceptor function in ROP children.
3,15,25,26 The new finding is that MDA is the decisive parameter that may be considered as an objective novel biomarker. The critical diameter for spatial summation was shown to be larger in subjects with a history of ROP than in preterm children who never had ROP and term-born controls.
27 This effect was interpreted as evidence of intralaminar reorganization of the postreceptor ROP retina.
27 The critical duration of the light stimulus for temporal summation was longer in subjects with a history of ROP than in preterm children who never had ROP, and was attributed to slow kinetics of activation of rod phototransduction in ROP.
2,27 Particularly interesting are results of an adaptive optics OCT study of the retinal laminae at 18° temporal eccentricity.
28 Akula et al.
28 found a higher ratio of postreceptor to photoreceptor thickness in ROP subjects than in term-born control subjects, which they interpreted as loss or disturbance of photoreceptors and compensation of the retina for altered photoreceptor inputs to the postreceptor retina.
27–29 We observed changed rod-kinetics at 12° temporal eccentricity, which means an area between the central fovea and the rod ring located at approximately 16° to 18°.
The rod photoreceptors are the last retinal cells to mature, except a relatively small number of foveal cones.
27,23 Additionally, the outer segments of the rods central to the rod ring undergo later developmental elongation than those peripheral to the ring, as a result of which dark-adapted visual thresholds central to the ring mature more slowly than those peripheral to the ring.
30 Persistent abnormalities of the intraretinal vasculature were revealed using different OCT-analyses.
15,31 In a longitudinal study of infants with a history of mild ROP, Barnaby et al.
32 found that, even though the clinical disease had resolved spontaneously and entirely by term, dark-adapted visual thresholds showed a protracted course of development that continued until 18 months post-term, whereas in term-born controls the thresholds were mature by the age of 6 months.
32 Matching these results, our measurement of the dark-adapted threshold after 20 minutes showed no statistically significant results between the children with and without morphologically changed fovea.
Reynaud et al.
33 found evidence that the neurosensory retina is involved in the ROP disease process by studying children and rat models of ROP. The escalating metabolic need of rods in the maturity process contributes to ROP. In rat models, rod photoreceptor dysfunction is detectable before vascular outcome.
27,34,35 It was shown that recovery of the ROP rat's post-receptor retinal sensitivity and retinal vasculature is under the cooperative control of growth factors.
36 In children, there are significant effects on retinal and visual function after the clinical resolution of ROP. In ERG-studies, infants (median 10 weeks) with a history of ROP, showed lower rod and rod-driven postreceptor sensitivity.
3 In children (median 10 years), postreceptor sensitivity normalized but the deficits in rod photoreceptor sensitivity persisted even when the ROP had been mild.
3 These data showed that after clinical healing, the postreceptor neural circuitry undergoes intralaminar reorganization.
37,38 Thus, it appears that rod photoreceptors are involved before, during, and after active ROP.
27 However, our results showed that reduced rod-mediated function may occur even in preterm-born children without ROP. This would indicate that prematurity as such is an important trigger for impaired retinal development involving the macula, that is, MDA.
We showed that cone photoreceptor function (i.e., visual acuity and final threshold after dark adaptation) was reduced in premature children with and without ROP. This difference was statistically significant, in particular in the presence of MDA. In addition, the severity of acute ROP also had a role although there were not enough patients in the different subgroups for statistical analysis (
Fig. 3). Previous studies had also shown similar effects on cone function in premature children with and without acute ROP.
39,40 However, at that time no correlation was made with MDA only visible with SD-OCT. It would be interesting to reexamine former patient cohorts with SD-OCT to see whether MDA also correlates with the reported functional deficits in those patients.
We showed, for the first time to our knowledge, a flatter S2 component of the dark adaptation course in young preterm-born children with and without spontaneously regressed ROP in the presence of MDA, but not with normal macular morphology. This demonstrated that MDA not only has significant long-term effects on central cone photoreceptors, affecting central photopic function seen with reduced light increment sensitivity (LIS), but also indicates a more widespread disturbance of rod photoreceptor function up to the morphologic rod ring where rod density is highest. The impairment is substantial and could affect the daily life of children, especially when rapidly changing lighting conditions occur from bright light to darker conditions (e.g., tunnel entries). Considering the findings of previous studies of preterm-born and ROP subjects,
3–5,11,15–17 our present results indicated that persistent malfunctioning of the photoreceptor outer segments may be present in preterm-born children, independent of ROP.